Lately, Emergency Use Listing (EUL) is granted to Wondfo 2019-nCoV Antigen Test (Lateral Flow Method) by WHO to enable procurement and decision. Wondfo is honored that our COVID-19 tests are appreciated for sound quality and performance.


Facing the initial outbreak of the pandemic, Wondfo was expedient in acting and developing COVID-19 tests. The COVID-19 antibody test, antigen test and antigen self-test are all among the first batch of tests approved by China’s National Medical Product Administrative (NMPA). Up to now, we have conducted assessment and verification of effectiveness in detecting major variants, and dozens of analysis essays have proved Wondfo 2019-nCoV Tests’ sound and stable performance in detecting various coronavirus variants, such as Delta, Omicron and recently emerging BA.4 and BA.5. Billions of our COVID-19 tests have been distributed worldwide, assisting in the global fight against the virus.
 
As a leader in POCT industry in China, Wondfo, with cutting-edge techniques, will continue to assist in the global prevention and control of the pandemic. Racing for Life.

View product detail of Wondfo 2019-nCoV Antigen Test granted with EUL